Michael A. Crackower

Also affiliated with Beam Therapeutics (United States), Xilio Therapeutics (United States)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Advances toward structure-based drug discovery for inflammasome targets”.

Advances toward structure-based drug discovery for inflammasome targets

The Journal of Experimental Medicine(2021)10.1084/jem.20211147

N/A

0DataRank · unranked

4 citations

Michael A. Crackower, Hao Wu, Li Wang

Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration

npj Dementia(2025)10.1038/s44400-025-00011-5

N/A

0DataRank · unranked

18 citations

Rania Faidi, Alexis Rickman, Carolina Pena Martinez, Austin Fajfer, Jeremy Carling +12 more